Danuta M. Skowronski - Publications

Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulation.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: May 16, 2026

AMMI Canada seasonal influenza guideline update 2025-26: Some questions answered.

Journal: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada

Published: May 14, 2026

Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies.

Journal: mBio

Published: April 13, 2026

2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada.

Journal: Vaccine

Published: March 19, 2026

Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 06, 2026

Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada.

Journal: Lancet regional health. Americas

Published: November 28, 2025

Methodological considerations in the attribution of long COVID to first or second infection.

Journal: The Lancet. Infectious diseases

Published: November 17, 2025

Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada.

Journal: The Journal of infectious diseases

Published: October 26, 2025

Influenza vaccination status ascertainment and vaccine effectiveness estimation: Validity of self-report for current and prior season.

Journal: Vaccine

Published: October 24, 2025

Effectiveness of 2024/25 KP.2 Vaccine Against Outpatient COVID-19 in Canada.

Journal: Influenza and other respiratory viruses

Published: October 09, 2025

Measles seroprevalence by birth cohort across the lifespan: a population-based, cross-sectional serosurvey in British Columbia, Canada.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: September 04, 2025

Emergence of seasonal influenza A(H3N2) variants with immune escape potential warrants enhanced molecular and epidemiological surveillance for the 2025-2026 season.

Journal: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada

Published: August 28, 2025